• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

红霉素对中国精神分裂症患者喹硫平代谢的影响。

Effect of erythromycin on metabolism of quetiapine in Chinese suffering from schizophrenia.

作者信息

Li Kun-Yan, Li Xin, Cheng Ze-Neng, Zhang Bi-Kui, Peng Wen-Xing, Li Huan-De

机构信息

Clinical Pharmaceutical Research Institute, Hunan Provincial Tumor Hospital of China, Changsha, China.

出版信息

Eur J Clin Pharmacol. 2005 Jan;60(11):791-5. doi: 10.1007/s00228-004-0853-x. Epub 2004 Dec 14.

DOI:10.1007/s00228-004-0853-x
PMID:15599502
Abstract

OBJECTIVE

To study the effect of erythromycin on metabolism of quetiapine in Chinese suffering from schizophrenia.

METHODS

Nineteen patients received multiple doses of quetiapine (200 mg, twice daily) with or without co-administered erythromycin (500 mg, three times daily). Blood samples were collected at specified time intervals for determination of plasma concentrations of quetiapine and some of its metabolites.

RESULTS

With erythromycin co-administration: for quetiapine, maximal plasma concentration (Cmax), area under concentration-time curve of 0-infinity h (AUC0-infinity) and terminal-phase elimination half-life time (t1/2) increased 68, 129 and 92%, respectively, and clearance (CL) and terminal elimination rate constant (Ke) decreased 52% and 55%, respectively; for quetiapine sulfoxide (QTP-SF), Cmax, AUC0-infinity and AUC ratio decreased 64, 23, and 70%, respectively, and t1/2 increased 211%; for 7-hydroxy-quetiapine (QTP-H), Ke and AUC ratio decreased 61% and 45%, respectively, and t1/2 increased 203%; for 7-hydroxy-N-desalkyl-quetiapine (QTP-ND), Cmax, AUC0-infinity and AUC ratio decreased 36, 40 and 71%, respectively.

CONCLUSION

Erythromycin has a noticeable effect on the metabolism of quetiapine. When quetiapine is co-administered with CYP3A inhibitors such as erythromycin, the dosing regimen should be modified according to quetiapine TDM.

摘要

目的

研究红霉素对中国精神分裂症患者喹硫平代谢的影响。

方法

19例患者接受多剂量喹硫平(200mg,每日两次),同时或不同时联合使用红霉素(500mg,每日三次)。在特定时间间隔采集血样,以测定喹硫平及其一些代谢产物的血浆浓度。

结果

联合使用红霉素时:对于喹硫平,血浆最大浓度(Cmax)、0至无穷大小时的浓度-时间曲线下面积(AUC0-无穷大)和终末相消除半衰期(t1/2)分别增加68%、129%和92%,清除率(CL)和终末消除速率常数(Ke)分别降低52%和55%;对于喹硫平亚砜(QTP-SF),Cmax、AUC0-无穷大及AUC比值分别降低64%、23%和70%,t1/2增加211%;对于7-羟基喹硫平(QTP-H),Ke和AUC比值分别降低61%和45%,t1/2增加203%;对于7-羟基-N-去烷基喹硫平(QTP-ND),Cmax、AUC0-无穷大及AUC比值分别降低36%、40%和71%。

结论

红霉素对喹硫平的代谢有显著影响。当喹硫平与红霉素等CYP3A抑制剂合用时,应根据喹硫平的血药浓度监测调整给药方案。

相似文献

1
Effect of erythromycin on metabolism of quetiapine in Chinese suffering from schizophrenia.红霉素对中国精神分裂症患者喹硫平代谢的影响。
Eur J Clin Pharmacol. 2005 Jan;60(11):791-5. doi: 10.1007/s00228-004-0853-x. Epub 2004 Dec 14.
2
Metabolic mechanism of quetiapine in vivo with clinical therapeutic dose.喹硫平在临床治疗剂量下的体内代谢机制。
Methods Find Exp Clin Pharmacol. 2005 Mar;27(2):83-6. doi: 10.1358/mf.2005.27.2.876282.
3
Pharmacokinetics and tolerability of extended-release quetiapine fumarate in Han Chinese patients with schizophrenia.富马酸喹硫平缓释片在中国汉族精神分裂症患者中的药代动力学和耐受性。
Clin Pharmacokinet. 2014 May;53(5):455-65. doi: 10.1007/s40262-013-0127-9.
4
Multiple dose pharmacokinetics of quetiapine and some of its metabolites in Chinese suffering from schizophrenia.
Acta Pharmacol Sin. 2004 Mar;25(3):390-4.
5
Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia.精神分裂症患者停用喹硫平(思瑞康)后中枢神经系统多巴胺 D2 和 5 - HT2 受体阻断的时间进程及血浆药物浓度
Psychopharmacology (Berl). 1998 Jan;135(2):119-26. doi: 10.1007/s002130050492.
6
Clinical pharmacokinetics of quetiapine: an atypical antipsychotic.喹硫平的临床药代动力学:一种非典型抗精神病药物。
Clin Pharmacokinet. 2001;40(7):509-22. doi: 10.2165/00003088-200140070-00003.
7
The effect of multiple doses of cimetidine on the steady-state pharmacokinetics of quetiapine in men with selected psychotic disorders.多次服用西咪替丁对患有特定精神障碍男性患者中喹硫平稳态药代动力学的影响。
J Clin Psychopharmacol. 2002 Apr;22(2):201-5. doi: 10.1097/00004714-200204000-00015.
8
Cytochrome P450 and ABCB1 genetics: association with quetiapine and norquetiapine plasma and cerebrospinal fluid concentrations and with clinical response in patients suffering from schizophrenia. A pilot study.细胞色素 P450 和 ABCB1 基因:与喹硫平和去甲喹硫平的血浆和脑脊液浓度以及精神分裂症患者临床反应的关联。一项初步研究。
J Psychopharmacol. 2011 Jul;25(7):896-907. doi: 10.1177/0269881110389208. Epub 2010 Dec 8.
9
Quetiapine serum concentrations in psychiatric patients: the influence of comedication.精神科患者的喹硫平血清浓度:合并用药的影响。
Ther Drug Monit. 2004 Oct;26(5):486-91. doi: 10.1097/00007691-200410000-00005.
10
Pharmacokinetic profile of the extended-release formulation of quetiapine fumarate (quetiapine XR): clinical implications.富马酸喹硫平缓释制剂的药代动力学特征:临床意义。
Curr Med Res Opin. 2013 Jul;29(7):813-25. doi: 10.1185/03007995.2013.794774. Epub 2013 Apr 30.

引用本文的文献

1
Optimization of initial dosage of quetiapine in schizophrenic patients: effects of fluvoxamine or duloxetine coadministration.精神分裂症患者喹硫平初始剂量的优化:氟伏沙明或度洛西汀联合用药的效果
Front Pharmacol. 2024 Nov 20;15:1496043. doi: 10.3389/fphar.2024.1496043. eCollection 2024.
2
Adverse events with quetiapine and clarithromycin coprescription: A population-based retrospective cohort study.喹硫平与克拉霉素联合处方的不良事件:一项基于人群的回顾性队列研究。
Health Sci Rep. 2023 Jun 23;6(6):e1375. doi: 10.1002/hsr2.1375. eCollection 2023 Jun.
3
Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents.

本文引用的文献

1
Simultaneous determination of quetiapine and three metabolites in human plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry.高效液相色谱-电喷雾电离质谱法同时测定人血浆中的喹硫平及其三种代谢物
Acta Pharmacol Sin. 2004 Jan;25(1):110-4.
2
The effect of erythromycin on the pharmacokinetics of rosuvastatin.红霉素对瑞舒伐他汀药代动力学的影响。
Eur J Clin Pharmacol. 2003 May;59(1):51-6. doi: 10.1007/s00228-003-0573-7. Epub 2003 Apr 1.
3
Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing.
非典型抗精神病药物与抗感染药物之间的临床相关相互作用
Pharmaceuticals (Basel). 2020 Dec 2;13(12):439. doi: 10.3390/ph13120439.
4
Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients.改善 COPD 加重管理中的抗菌药物处方安全性:系统评价观察性和临床研究,评估 COPD 患者中常用抗菌药物相关的潜在药物相互作用。
J Antimicrob Chemother. 2019 Oct 1;74(10):2848-2864. doi: 10.1093/jac/dkz221.
5
Clinically significant drug interactions with atypical antipsychotics.非典型抗精神病药物的具有临床意义的药物相互作用。
CNS Drugs. 2013 Dec;27(12):1021-48. doi: 10.1007/s40263-013-0114-6.
6
Quetiapine in the treatment of schizophrenia and related disorders.喹硫平治疗精神分裂症及相关障碍。
Neuropsychiatr Dis Treat. 2007 Apr;3(2):219-35. doi: 10.2147/nedt.2007.3.2.219.
喹硫平:临床前研究、药代动力学、药物相互作用及给药剂量
J Clin Psychiatry. 2002;63 Suppl 13:5-11.
4
Clinical pharmacokinetics of quetiapine: an atypical antipsychotic.喹硫平的临床药代动力学:一种非典型抗精神病药物。
Clin Pharmacokinet. 2001;40(7):509-22. doi: 10.2165/00003088-200140070-00003.
5
The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine.同时服用苯妥英对喹硫平稳态药代动力学的影响。
J Clin Psychopharmacol. 2001 Feb;21(1):89-93. doi: 10.1097/00004714-200102000-00016.
6
Quetiapine: a review of its safety in the management of schizophrenia.
Drug Saf. 2000 Oct;23(4):295-307. doi: 10.2165/00002018-200023040-00003.
7
Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders.富马酸喹硫平的药代动力学、耐受性及临床疗效:一项针对患有精神疾病青少年的开放标签试验。
J Clin Psychiatry. 2000 Apr;61(4):252-60. doi: 10.4088/jcp.v61n0403.
8
Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia.精神分裂症患者停用喹硫平(思瑞康)后中枢神经系统多巴胺 D2 和 5 - HT2 受体阻断的时间进程及血浆药物浓度
Psychopharmacology (Berl). 1998 Jan;135(2):119-26. doi: 10.1007/s002130050492.
9
Drug treatment of the negative symptoms of schizophrenia.
Eur Neuropsychopharmacol. 1998 Feb;8(1):33-42. doi: 10.1016/s0924-977x(97)00041-2.
10
Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.“思瑞康”(喹硫平)多固定剂量用于精神分裂症急性加重患者:与氟哌啶醇和安慰剂的比较。思瑞康试验13研究组
Biol Psychiatry. 1997 Aug 15;42(4):233-46. doi: 10.1016/s0006-3223(97)00190-x.